These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15979659)

  • 1. Predicting the risk of developmental toxicity from in vitro assays.
    Spielmann H
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):375-80. PubMed ID: 15979659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and interpretation of maternal toxicity in Segment II studies: issues, some answers, and data needs.
    Rogers JM; Chernoff N; Keen CL; Daston GP
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):367-74. PubMed ID: 15982694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test.
    zur Nieden NI; Davis LA; Rancourt DE
    Toxicol Appl Pharmacol; 2010 Sep; 247(2):91-7. PubMed ID: 20576515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New models and molecular markers in evaluation of developmental toxicity.
    Huuskonen H
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):495-500. PubMed ID: 15990136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental toxicity testing from animal towards embryonic stem cells.
    Pellizzer C; Bremer S; Hartung T
    ALTEX; 2005; 22(2):47-57. PubMed ID: 15953962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cell and micromass culture in assessing developmental toxicity.
    Pratten M; Ahir BK; Smith-Hurst H; Memon S; Mutch P; Cumberland P
    Methods Mol Biol; 2012; 889():115-46. PubMed ID: 22669663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental toxicology: adequacy of current methods.
    Peters PW
    Food Addit Contam; 1998; 15 Suppl():55-62. PubMed ID: 9602913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of alternative methods for developmental toxicity testing.
    Piersma AH
    Toxicol Lett; 2004 Apr; 149(1-3):147-53. PubMed ID: 15093260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro.
    Buesen R; Genschow E; Slawik B; Visan A; Spielmann H; Luch A; Seiler A
    Toxicol Sci; 2009 Apr; 108(2):389-400. PubMed ID: 19168572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ culture of the fetal mouse palate for screening the developmental toxicity of chemicals: a validation study.
    Kosazuma T; Hashimoto S; Ohno H; Chou MJ; Shiota K
    Congenit Anom (Kyoto); 2004 Jun; 44(2):60-71. PubMed ID: 15198718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling.
    Verwei M; van Burgsteden JA; Krul CA; van de Sandt JJ; Freidig AP
    Toxicol Lett; 2006 Aug; 165(1):79-87. PubMed ID: 16517103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of human embryonic stem cell-based models for male reproductive toxicity screening.
    Krtolica A; Giritharan G
    Syst Biol Reprod Med; 2010 Jun; 56(3):213-21. PubMed ID: 20536321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of drug induced developmental toxicity using human embryonic stem cells.
    Mehta A; Konala VB; Khanna A; Majumdar AS
    Cell Biol Int; 2008 Nov; 32(11):1412-24. PubMed ID: 18778783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.
    Silva MH; Gammon D
    Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):1-28. PubMed ID: 19243027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications.
    Daston GP
    Teratology; 1996 Jun; 53(6):339-44. PubMed ID: 8910979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.